|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Lipitor (atorvastatin calcium) tablets, Parke-Davis Pharmaceutical Research, agent for Warner-Lambert Export, Limited NDA 20-702
/S-003/S-005 7/10/98 7/10/98 11/12/98
Lipitor Indications: S-003 provides for the use of Lipitor as an adjunctive therapy to diet for the treatment of patients with elevated serium triglyceride levels (Frederickson Type IV). S-005 provides for the use of Lipitor by patients with primary dysbetalipoproteinemia (Frederickson Type III) who do not respond adequately to diet.
Lipitor (atorvastatin calcium) tablets, Parke-Davis Pharmaceutical Research, agent for Warner-Lambert Export, Limited NDA 20-702
/S-004 2/2/98 10/23/98
Lipitor (atorvastatin calcium) tablets, Parke-Davis Pharmaceutical Research, agent for Warner-Lambert Export, Limited NDA 20-702
/S-14 8/28/98 12/14/98
Lipitor (atorvastatin calcium) tablets, Parke-Davis, agent for Warner-Lambert Export, Limited NDA 20-702
/S-18 12/2/99 12/29/99 4/23/03
Lipitor (atorvastatin calcium) Tablets, Pfizer Ireland NDA 20-702
/S-25 6/15/01 11/6/01 11/6/01 4/10/02
Lipitor (atorvastatin calcium) Tablets, Pfizer, NDA 20-702/S-33 10/18/02 10/28/02 10/18/02
Lipitor (atorvastatin calcium) Tablets, Pfizer Ireland NDA 20-702
/S29 & S34 4/22/02 5/2/02 4/24/02
Lipitor (atorvastatin calcium) Tablets, Pfizer NDA 20-702/S37 9/29/03 10/9/03 10/10/03
Lipitor (atorvastatin calcium) Tablets, Pfizer NDA 20-702/S36 Caduet (amlodipine besylate/atorvastatin calcium) Tablets, Pfizer Inc. Lipitor (Atorvastatin calcium) tablets, Pfizer Lipitor (Atorvastatin calcium) tablets, Pfizer Inc., New or Modified Indication | Caduet (amlodipine besylate/atorvastatin calcium) Tablets, Pfizer Inc., Supplement | Lipitor (Atorvastatin calcium) tablets, Pfizer Inc., Labeling Revision | Caduet (amlodipine besylate and atorvastatin calcium) Tablets, Pfizer, Labeling Revision | Lipitor (atorvastatin calcium) Tablets, Pfizer Inc., Labeling Revision | Lipitor (atorvastatin calcium) Tablets, Pfizer Inc., Labeling Revision | Caduet Tablet, Pfizer, Labeling Revision | Lipitor (atorvastatin calcium) Tablets, Pfizer, New or Modified Indication
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|